These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 37368455)

  • 21. Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma.
    Chari A; Vogl DT; Gavriatopoulou M; Nooka AK; Yee AJ; Huff CA; Moreau P; Dingli D; Cole C; Lonial S; Dimopoulos M; Stewart AK; Richter J; Vij R; Tuchman S; Raab MS; Weisel KC; Delforge M; Cornell RF; Kaminetzky D; Hoffman JE; Costa LJ; Parker TL; Levy M; Schreder M; Meuleman N; Frenzel L; Mohty M; Choquet S; Schiller G; Comenzo RL; Engelhardt M; Illmer T; Vlummens P; Doyen C; Facon T; Karlin L; Perrot A; Podar K; Kauffman MG; Shacham S; Li L; Tang S; Picklesimer C; Saint-Martin JR; Crochiere M; Chang H; Parekh S; Landesman Y; Shah J; Richardson PG; Jagannath S
    N Engl J Med; 2019 Aug; 381(8):727-738. PubMed ID: 31433920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple myeloma.
    Kumar SK; Rajkumar V; Kyle RA; van Duin M; Sonneveld P; Mateos MV; Gay F; Anderson KC
    Nat Rev Dis Primers; 2017 Jul; 3():17046. PubMed ID: 28726797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting Cancer at the Nuclear Pore.
    Azmi AS; Mohammad RM
    J Clin Oncol; 2016 Dec; 34(34):4180-4182. PubMed ID: 27863200
    [No Abstract]   [Full Text] [Related]  

  • 24. IMiD immunomodulatory compounds block C/EBP{beta} translation through eIF4E down-regulation resulting in inhibition of MM.
    Li S; Pal R; Monaghan SA; Schafer P; Ouyang H; Mapara M; Galson DL; Lentzsch S
    Blood; 2011 May; 117(19):5157-65. PubMed ID: 21389327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting eukaryotic translation initiation factor 4E (eIF4E) in cancer.
    Hsieh AC; Ruggero D
    Clin Cancer Res; 2010 Oct; 16(20):4914-20. PubMed ID: 20702611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Principles of cancer therapy: oncogene and non-oncogene addiction.
    Luo J; Solimini NL; Elledge SJ
    Cell; 2009 Mar; 136(5):823-37. PubMed ID: 19269363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A wholesale approach to disarm multiple myeloma.
    Cenci S
    Blood Adv; 2023 Jun; 7(12):2938-2939. PubMed ID: 37368455
    [No Abstract]   [Full Text] [Related]  

  • 28. Multiple myeloma.
    White TB; Caldwell D; Hall-Rollins J
    Radiol Technol; 2005; 76(5):379-88; quiz 389-91. PubMed ID: 15921017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple myeloma: Every year a new standard?
    Rajkumar SV
    Hematol Oncol; 2019 Jun; 37 Suppl 1(Suppl 1):62-65. PubMed ID: 31187526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The diagnosis of multiple myeloma].
    Bartl R; Fateh-Moghadam A
    Onkologie; 1986 Aug; 9(4):183-8, 190-5. PubMed ID: 3531945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnostic criteria of multiple myeloma].
    Hata H
    Nihon Rinsho; 2015 Jan; 73(1):13-5. PubMed ID: 25626297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple myeloma: diagnosis and treatment.
    Nau KC; Lewis WD
    Am Fam Physician; 2008 Oct; 78(7):853-9. PubMed ID: 18841734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The significance and current diagnostic options of cytogenetic changes in multiple myeloma].
    Kuglík P; Filková H; Oltová A; Hájek R
    Vnitr Lek; 2006 Nov; 52 Suppl 2():76-8. PubMed ID: 18175433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple myeloma and diagnostic imaging.
    Reisenbuckler C
    Radiol Technol; 2014; 85(4):391-410; quiz 411-3. PubMed ID: 24614435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current problems in the diagnosis and treatment of myeloma disease].
    Alekseev GA
    Klin Med (Mosk); 1983 May; 61(5):8-12. PubMed ID: 6348403
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prognositic factors in multiple myeloma].
    Nagura E
    Nihon Rinsho; 2007 Dec; 65(12):2351-6. PubMed ID: 18069282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in myeloma genetics and prospects for pharmacogenomic testing in multiple myeloma.
    Claudio JO; Stewart AK
    Am J Pharmacogenomics; 2005; 5(1):35-43. PubMed ID: 15727487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple myeloma: recognition and management.
    George ED; Sadovsky R
    Am Fam Physician; 1999 Apr; 59(7):1885-94. PubMed ID: 10208707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extramedullary multiple myeloma.
    Weinstock M; Ghobrial IM
    Leuk Lymphoma; 2013 Jun; 54(6):1135-41. PubMed ID: 23210572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging of extraosseous myeloma: CT, PET/CT, and MRI features.
    Hall MN; Jagannathan JP; Ramaiya NH; Shinagare AB; Van den Abbeele AD
    AJR Am J Roentgenol; 2010 Nov; 195(5):1057-65. PubMed ID: 20966307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.